Evaluating ADGRB3 as a tumor suppressor epigenetically silenced in WNT medulloblastoma

评估 ADGRB3 作为 WNT 髓母细胞瘤中表观遗传沉默的肿瘤抑制因子

基本信息

  • 批准号:
    10599504
  • 负责人:
  • 金额:
    $ 2.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-01 至 2025-01-31
  • 项目状态:
    未结题

项目摘要

RESEARCH, MENTORING, AND CAREER DEVELOPMENT PLAN: RESEARCH PLAN: Project Summary/Abstract of Funded Parent Grant: There is an urgent need to develop novel therapies for patients with medulloblastoma (MB), the most common malignant central nervous system (CNS) tumor in children. Current treatments include surgery, radiotherapy, and chemotherapy and result in 5-year survival rates of 40-90% depending on subtype. However, children suffer important morbidity secondary to treatment, including neurological, intellectual and physical disabilities. The overall purpose of the present project is to investigate the role of the ADGRB3 receptor in susceptibility of cerebellar transformation, and explore new therapies for MB based on the related mechanisms. ADGRB3 is an orphan seven transmembrane G protein-coupled receptor (GPCR) specifically expressed in the brain, and belonging to the adhesion-type sub-family. Our new preliminary data show that ADGRB3 expression is significantly reduced in patients with MBs of the WNT group, and the promoter is epigenetically silenced, suggesting that ADGRB3 loss may facilitate WNT-MB formation. We present evidence for the involvement of methylated CpG binding protein MBD2 and histone methyltransferase EZH2 in switch to a silent chromatin. Moreover, we show that reactivation of ADGRB3 can reduce cell proliferation and tumor growth, supporting a tumor suppressive role. To test this in the physiological setting, we generated ADGRB3 knockout (KO) mice, which we plan to cross with mice expressing mutant b-catenin in neural progenitors of the rhombic lip and dorsal brainstem, which are the cells of origin of WNT-MB. Based on these results, we hypothesize that ADGRB3 is a tumor suppressor in the cerebellum and that restoration of its expression with epigenetic therapy may represent a novel therapeutic intervention for children with WNT-MB. To test our hypothesis, we propose the following aims: (i) identify and target the epigenetic mechanism(s) underlying ADGRB3 gene silencing in WNT-MB, (ii) determine whether and how restoration of ADGRB3 expression can inhibit MB cell growth, oncogenic signaling and tumorigenic properties, and (iii) determine whether loss of ADGRB3 gene expression in the background of oncogenic Ctnnb1 activation predisposes mice to cerebellar transformation and MB tumor development. These studies are important as they increase our knowledge about developmental neurobiology in the CNS, and may lead to the development of novel therapeutic approaches for patients with medulloblastoma.
研究、指导和职业发展规划:

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ERWIN G VAN MEIR其他文献

ERWIN G VAN MEIR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ERWIN G VAN MEIR', 18)}}的其他基金

Mechanisms underlying BAI1/ADGRB1 negative regulation of glioblastoma mesenchymal transition and invasion.
BAI1/ADGRB1 胶质母细胞瘤间质转化和侵袭负调控的机制。
  • 批准号:
    10034438
  • 财政年份:
    2021
  • 资助金额:
    $ 2.6万
  • 项目类别:
Mechanisms underlying BAI1/ADGRB1 negative regulation of glioblastoma mesenchymal transition and invasion.
BAI1/ADGRB1 胶质母细胞瘤间质转化和侵袭负调控的机制。
  • 批准号:
    10488569
  • 财政年份:
    2021
  • 资助金额:
    $ 2.6万
  • 项目类别:
Mechanisms underlying BAI1/ADGRB1 negative regulation of glioblastoma mesenchymal transition and invasion.
BAI1/ADGRB1 胶质母细胞瘤间质转化和侵袭负调控的机制。
  • 批准号:
    10687227
  • 财政年份:
    2021
  • 资助金额:
    $ 2.6万
  • 项目类别:
Targeting Mechanisms of Medulloblastoma Formation
髓母细胞瘤形成的靶向机制
  • 批准号:
    10179178
  • 财政年份:
    2020
  • 资助金额:
    $ 2.6万
  • 项目类别:
Evaluating ADGRB3 as a tumor suppressor epigenetically silenced in WNT medulloblastoma
评估 ADGRB3 作为 WNT 髓母细胞瘤中表观遗传沉默的肿瘤抑制因子
  • 批准号:
    9965891
  • 财政年份:
    2019
  • 资助金额:
    $ 2.6万
  • 项目类别:
Evaluating ADGRB3 as a tumor suppressor epigenetically silenced in WNT medulloblastoma
评估 ADGRB3 作为 WNT 髓母细胞瘤中表观遗传沉默的肿瘤抑制因子
  • 批准号:
    10358481
  • 财政年份:
    2019
  • 资助金额:
    $ 2.6万
  • 项目类别:
Evaluating ADGRB3 as a tumor suppressor epigenetically silenced in WNT medulloblastoma
评估 ADGRB3 作为 WNT 髓母细胞瘤中表观遗传沉默的肿瘤抑制因子
  • 批准号:
    10057681
  • 财政年份:
    2019
  • 资助金额:
    $ 2.6万
  • 项目类别:
Evaluating ADGRB3 as a tumor suppressor epigenetically silenced in WNT medulloblastoma
评估 ADGRB3 作为 WNT 髓母细胞瘤中表观遗传沉默的肿瘤抑制因子
  • 批准号:
    10583473
  • 财政年份:
    2019
  • 资助金额:
    $ 2.6万
  • 项目类别:
Evaluating ADGRB3 as a tumor suppressor epigenetically silenced in WNT medulloblastoma
评估 ADGRB3 作为 WNT 髓母细胞瘤中表观遗传沉默的肿瘤抑制因子
  • 批准号:
    10738336
  • 财政年份:
    2019
  • 资助金额:
    $ 2.6万
  • 项目类别:
Targeting mechanisms of medulloblastoma formation
髓母细胞瘤形成的靶向机制
  • 批准号:
    9213395
  • 财政年份:
    2016
  • 资助金额:
    $ 2.6万
  • 项目类别:

相似海外基金

The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
  • 批准号:
    EP/Z000920/1
  • 财政年份:
    2025
  • 资助金额:
    $ 2.6万
  • 项目类别:
    Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
  • 批准号:
    FT230100276
  • 财政年份:
    2024
  • 资助金额:
    $ 2.6万
  • 项目类别:
    ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
  • 批准号:
    MR/X024261/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.6万
  • 项目类别:
    Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
  • 批准号:
    DE240100388
  • 财政年份:
    2024
  • 资助金额:
    $ 2.6万
  • 项目类别:
    Discovery Early Career Researcher Award
Zootropolis: Multi-species archaeological, ecological and historical approaches to animals in Medieval urban Scotland
Zootropolis:苏格兰中世纪城市动物的多物种考古、生态和历史方法
  • 批准号:
    2889694
  • 财政年份:
    2023
  • 资助金额:
    $ 2.6万
  • 项目类别:
    Studentship
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
  • 批准号:
    2842926
  • 财政年份:
    2023
  • 资助金额:
    $ 2.6万
  • 项目类别:
    Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
  • 批准号:
    NC/X001644/1
  • 财政年份:
    2023
  • 资助金额:
    $ 2.6万
  • 项目类别:
    Training Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
  • 批准号:
    2337595
  • 财政年份:
    2023
  • 资助金额:
    $ 2.6万
  • 项目类别:
    Continuing Grant
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
  • 批准号:
    2232190
  • 财政年份:
    2023
  • 资助金额:
    $ 2.6万
  • 项目类别:
    Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
  • 批准号:
    23K17514
  • 财政年份:
    2023
  • 资助金额:
    $ 2.6万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了